ETFs Holding CRIS »    CRIS Historical Stock Prices »
CRIS News Video: Mon, May 21, 2018, 1:07 PM — Monday Sector Laggards: Biotechnology, Drugs

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Curis is a biotechnology company. Co. develops and commercializes drug candidates for the treatment of human cancers. Co.'s clinical stage drug candidates are: CUDC-907, which is in a Phase 2 clinical trial in patients with MYC-altered diffuse large B-cell lymphoma and solid tumors; CA-170, which is in a Phase 1 study in patients with solid tumors and lymphomas; and CA-4948, which is in a Phase 1 trial in patients with non-Hodgkin lymphomas, including those with the myeloid differentiation primary response 88 alterations. Co.'s pipeline also includes CA-327, an oral small molecule drug candidate that is designed to selectively target PDL1 and TIM3 immune checkpoint proteins. Self directed investors in Curis Inc will be interested in keeping up with all Curis Inc news they can find, both CRIS news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on CRIS. At RediNews, we simplify this task by presenting both CRIS news releases originating from Curis Inc itself, and CRIS news from a variety of media outlets. Visitors can browse this news online and through our CRIS RSS news feed.


CRIS News — Articles, Videos, & Press Releases

CRIS is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

CMN News

RediNews invites financial news content websites to integrate our XML content for web sites by integrating our RSS feeds found throughout our website wherever news and stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic content is ideal for any financial portal or web portal, from business content web sites to corporate portal intranets. Let RediNews be your content provider of free financial content for news, perfect for location on stock market chart pages by symbol, adding another element of dynamic stock market content to your financial portal. If your web page content already includes elements like SEC filings, screener pages, historical chart information, and other cobranded financial web content, then headlines from RediNews can supplement this dynamic financial content meaningfully.

CRIS News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.